Fabius Anesthesia Machines by Dräger Medical: Class I Recall - Due to Production Step Error

ISSUE: Dräger Medical is recalling the Fabius Anesthesia machines due to excessive oil that was not removed at the time of production. Such excess oil may interfere with the position detector of the ventilation motor during operation and may cause ventilation to fail. A halt in ventilation may lead to serious adverse health consequences, including patient injury or death.

Model/Item Numbers: See complete lists for Fabius GS Premium, Fabius Tiro, Fabius Tiro M, Fabius MRI Anesthesia Machines

Sugarfina, Inc. Issues Allergen Labeling Alert for Undeclared Eggs in Sugar Cookies Product

Sugarfina, Inc. is recalling its Sugar Cookies product because the label does not declare that this product contains egg. People who have allergies or severe sensitivities to eggs run the risk of serious or life-threatening allergic reaction if they consume this product.

Auromedics Pharma LLC Issues Voluntary Nationwide Recall of Product Piperacillin and Tazobactam For Injection 3.375 Grams Per Vial, Due to Presence of Glass Particulates

AuroMedics Pharma LLC is voluntarily recalling two lots of Piperacillin and Tazobactam for injection, USP 3.375 g (Piperacillin Sodium equivalent to 3 g of Piperacillin USP and Tazobactam Sodium equivalent to 0.375 g of Tazobactam USP. Each vial contains 7.05 mEq (162 mg) of Sodium) in a Single-Dose vial, to the hospital level. The products have been found to contain particulate matter, visible only after reconstitution that was confirmed to be glass within the vial.

Apotex Corp. Issues Voluntary Nationwide Recall of Piperacillin and Tazobactam For Injection, USP 3.375 Gram/Vial And 4.5 Gram/Vial Strengths Due to Elevated Levels of Impurities That May Result in Decreased Potency

Apotex Corp. is voluntarily recalling 36 lots of Piperacillin and Tazobactam for Injection, USP 3.375 gram/vial and 4.5 gram/vial strengths, to the consumer/user level. The Piperacillin and Tazobactam for Injection have been found to contain elevated levels of impurities that may result in decreased potency. The affected product is manufactured by Hospira Inc., a Pfizer Company and distributed in the US market by Apotex Corp.

Recall of Certain Lots of Izzy’s Maple Nut Ice Cream Due to Undeclared Peanuts

Category: 

Izzy’s Ice Cream, LLC is voluntarily recalling limited numbers of its Maple Nut Ice Cream pints following a supplier’s recall of walnuts due to the possible presence of undeclared peanut residue. People who have an allergy or severe sensitivity to peanuts run the risk of serious or life-threatening allergic reaction if they consume these products

Product Information

The products were produced on January 29th, 2018, February 6th, 2018, February 12th, 2018, February 19th, 2018 and February 27th, 2018 and can be identified by the following codes on the bottom of the pint:

Pages

User login

CAPTCHA
This question is for testing whether you are a human visitor and to prevent automated spam submissions.